SAN JOSE, Calif., Oct. 9 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the third quarter ended September 30, 2007, before market opens on October 29.
VNUS plans to host its regular quarterly teleconference at 5:30 a.m. PT / 8:30 a.m. ET on October 29. This call will be webcast live for all investors and archived on the company’s website at http://www.vnus.com.
Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly. In addition to the webcast replay, a phone replay will be available for seven days after the live call at (719) 457-0820, code number 7307148.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of symptomatic varicose veins. VNUS sells the VNUS Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at http://www.vnus.com.
CONTACT: Peter Osborne, Interim Chief Financial Officer of VNUS Medical
Technologies, Inc., +1-408-360-7499, ir@vnus.com
Web site: http://www.vnus.com/
